Spotlight on Stem Cells

Elaine Fuchs and Craig Venter touted the promise of stem cell research at the American Society for Cell Biology annual meeting.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Elaine Fuchs, Craig VenterROCKEFELLER UNIVERSITY/J. CRAIG VENTER INSTITUTEDiscussing her work to decipher the transition from stem cell quiescence to activation at the American Society for Cell Biology (ASCB) annual meeting this week, Rockefeller University’s Elaine Fuchs said that for as much as researchers know about these progenitor cells, there is much left to learn. “There is a lot of exciting science left to do in the stem cell field,” Fuchs said during her keynote talk on the biology of stem cells, in which she spoke about her group’s work investigating cancer stem cells and the niche-specific signals that instruct stem cells to divide at certain times, like during periods of hair growth.

Craig Venter took the stage immediately after Fuchs. “I learned tonight that I am not bald, I just have quiescent stem cells,” he joked. In his talk, Venter noted that advances in single-cell sequencing technology and synthetic genomics have been a boon for stem cell research, allowing researchers to pinpoint the genetics of stemness. He and his colleagues are now “developing methods to rewrite the genetic code of stem cells,” he said.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies